CCN2 and breast cancer: Importantly, MAP3K3 knockdown reduced YAP expression in palbociclib-resistant breast cancer cells (Fig. 4e) and downregulated the expression of the YAP target genes CTGF, CYR61, and ANKRD1 (Fig. 4f).